Suppr超能文献

肝脏非实质细胞对带有末端甘露糖和N-乙酰葡糖胺的糖蛋白的血浆清除率。β-葡萄糖醛酸酶、N-乙酰-β-D-氨基葡萄糖苷酶、核糖核酸酶B和去半乳糖岩藻糖蛋白的研究。

Plasma clearance of glycoproteins with terminal mannose and N-acetylglucosamine by liver non-parenchymal cells. Studies with beta-glucuronidase, N-acetyl-beta-D-glucosaminidase, ribonuclease B and agalacto-orosomucoid.

作者信息

Schlesinger P H, Doebber T W, Mandell B F, White R, DeSchryver C, Rodman J S, Miller M J, Stahl P

出版信息

Biochem J. 1978 Oct 15;176(1):103-9. doi: 10.1042/bj1760103.

Abstract

Glycoproteins having mannose and/or N-acetylglucosamine in the terminal non-reducing position [Stockert, Morell & Scheinberg (1976) Biochem. Biophys. Res. Commun. 68, 988--993], and various lysosomal enzymes [Stahl, Schlesinger, Rodman & Doebber (1976) Nature (London) 264, 86--8] are rapidly cleared from plasma by the liver after intravenous administration. A liver cell-separation technique was used to determine the cellular localization of 125I-labelled beta-glucuronidase, ribonuclease B, agalacto-orosomucoid and asialo-orosomucoid. On a specific readioactivity basis, all ligands except 125I-labelled asialo-orosomucoid were enriched in the non-parenchymal cell fraction. Isolated cells, fixed and stained for beta-glucuronidase or N-acetyl-beta-D-glucosaminidase activity after intravenous injection of the enzymes, showed enrichment in the non-parenchymal cell fraction (probably Kupffer cells). After uptake by the non-parenchymal cells, liver lysosomal beta-glucuronidase and N-acetyl-beta-D-glucosaminidase showed degradation half-times of 2.2 and 0.4 days respectively.

摘要

在末端非还原位置含有甘露糖和/或N-乙酰葡糖胺的糖蛋白[斯托克特、莫雷尔和申伯格(1976年),《生物化学与生物物理学研究通讯》68卷,988 - 993页],以及各种溶酶体酶[施塔尔、施莱辛格、罗德曼和多贝伯(1976年),《自然》(伦敦)264卷,86 - 8页]在静脉注射后会被肝脏迅速从血浆中清除。采用肝细胞分离技术来确定125I标记的β-葡萄糖醛酸酶、核糖核酸酶B、去半乳糖-血清类粘蛋白和脱唾液酸血清类粘蛋白的细胞定位。基于比放射性,除125I标记的脱唾液酸血清类粘蛋白外,所有配体在非实质细胞部分均有富集。在静脉注射这些酶后,对分离的细胞进行固定并染色以检测β-葡萄糖醛酸酶或N-乙酰-β-D-葡糖胺酶活性,结果显示在非实质细胞部分(可能是库普弗细胞)有富集。非实质细胞摄取后,肝脏溶酶体β-葡萄糖醛酸酶和N-乙酰-β-D-葡糖胺酶的降解半衰期分别为2.2天和0.4天。

相似文献

引用本文的文献

2
Transcriptomics as a predictor of biopharmaceutically favourable glycan profiles.转录组学作为生物制药有利聚糖谱的预测指标
Front Cell Dev Biol. 2024 Dec 17;12:1504381. doi: 10.3389/fcell.2024.1504381. eCollection 2024.
6
Strategies for Glycoengineering Therapeutic Proteins.糖基工程改造治疗性蛋白质的策略
Front Chem. 2022 Apr 13;10:863118. doi: 10.3389/fchem.2022.863118. eCollection 2022.

本文引用的文献

1
ANTIGEN-ANTIBODY CROSSED ELECTROPHORESIS.抗原-抗体交叉电泳
Anal Biochem. 1965 Feb;10:358-61. doi: 10.1016/0003-2697(65)90278-2.
4
Electrophoretic separation of esterases of pulmonary alveolar cells.
J Histochem Cytochem. 1970 Mar;18(3):167-77. doi: 10.1177/18.3.167.
5
Functions of lysosomes.溶酶体的功能。
Annu Rev Physiol. 1966;28:435-92. doi: 10.1146/annurev.ph.28.030166.002251.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验